CSMS 53599807PGAOTHERrate change

Temporary Duty-Free Treatment for FDA-Authorized Parties of Infant Formula Base Powder

Published Oct 12, 2022

Summary

CBP announces temporary duty-free treatment, per HR 8982, for certain FDA-authorized infant formula base powder entered between October 13 and December 31, 2022, subject to quota and specific export deadlines.

Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.

CSMS 53599807 · full bulletin